Denna sida på svenska

Hayrettin Guven

Associated

Publications

Decreased decorin expression in the tumor microenvironment
Bozoky B, Savchenko A, Guven H, Ponten F, Klein G, Szekely L
Cancer medicine 2014;3(3):485-91

Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
Alkasalias T, Flaberg E, Kashuba V, Alexeyenko A, Pavlova T, Savchenko A, et al
Proceedings of the National Academy of Sciences of the United States of America 2014;111(48):17188-93

Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan
Cheng Hh, Kuo Cc, Yan Jl, Chen Hl, Lin Wc, Wang Kh, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2012;109(33):13231-6

The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth
Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L, et al
International journal of cancer 2012;131(10):2274-83

Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study
Ingram W, Chan L, Guven H, Darling D, Kordasti S, Hardwick N, et al
BRITISH JOURNAL OF HAEMATOLOGY 2009;145(6):749-60

NK Cell-Mediated Immunologic Responses Against Myeloma by B7-1 (CD80)/IL-2 Immune Gene Therapy
Guven H, Chan L, Darling D, Schey S, Mufti G, Farzaneh F
CLINICAL LYMPHOMA & MYELOMA 2009;:S135-S136

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
Barkholt L, Alici E, Conrad R, Sutlu T, Gilljam M, Stellan B, et al
IMMUNOTHERAPY 2009;1(5):753-64

In-Vitro Culture of Human CD80/IL2 Lentivirus Transduced Acute Myeloid Leukemia Cells (AML) Promote NK Cell Activation and Cytolytic Activity
Ingram W, Chan L, Guven H, Kordasti S, Barber L, Hardwick N, et al
BLOOD 2008;112(11):1020-1020

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice
Guimaraes F, Guven H, Donati D, Christensson B, Ljunggren Hg, Bejarano Mt, et al
LEUKEMIA 2006;20(5):833-9

Efficient gene transfer into primary human natural killer cells by retroviral transduction
Guven H, Konstantinidis Kv, Alici E, Aints A, Abedi-valugerdi M, Christensson B, et al
EXPERIMENTAL HEMATOLOGY 2005;33(11):1320-8

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy
Guven H, Gilljam M, Chambers Bj, Ljunggren Hg, Christensson B, Kimby E, et al
LEUKEMIA 2003;17(10):1973-80

Enhanced ouabain resistance gene as a eukaryotic selection marker
Aints A, Belusa R, Andersson Rm, Guven H, Dilber Ms
HUMAN GENE THERAPY 2002;13(8):969-77

A new method for in vitro expansion of cytotoxic human CD3(-)CD56(+) natural killer cells
Carlens S, Gilljam M, Chambers Bj, Aschan J, Guven H, Ljunggren Hg, et al
HUMAN IMMUNOLOGY 2001;62(10):1092-8

Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting
Aints A, Guven H, Gahrton G, Smith Cie, Dilber Ms
GENE THERAPY 2001;8(14):1051-6

Show all publications